Join Dementia Research latest newsView all news →

FEATURED ARTICLE

31 October 2024

Donanemab – an update

Last week it was announced that the dementia drug, donanemab, has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA). This means it will be available under private...

Browse news by topic